nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B3—Paclitaxel—lung cancer	0.107	0.158	CbGbCtD
Olmesartan—SLCO1B3—Docetaxel—lung cancer	0.0771	0.114	CbGbCtD
Olmesartan—SLCO1B1—Irinotecan—lung cancer	0.0613	0.0909	CbGbCtD
Olmesartan—SLCO1B3—Methotrexate—lung cancer	0.0557	0.0826	CbGbCtD
Olmesartan—ABCC2—Paclitaxel—lung cancer	0.0546	0.081	CbGbCtD
Olmesartan—ABCC2—Irinotecan—lung cancer	0.0539	0.0799	CbGbCtD
Olmesartan—ABCC2—Vinblastine—lung cancer	0.0479	0.071	CbGbCtD
Olmesartan—ABCC2—Cisplatin—lung cancer	0.0439	0.0651	CbGbCtD
Olmesartan—ABCC2—Etoposide—lung cancer	0.0431	0.064	CbGbCtD
Olmesartan—ABCC2—Docetaxel—lung cancer	0.0395	0.0586	CbGbCtD
Olmesartan—SLCO1B1—Methotrexate—lung cancer	0.0324	0.0481	CbGbCtD
Olmesartan—ABCC2—Doxorubicin—lung cancer	0.0294	0.0437	CbGbCtD
Olmesartan—ABCC2—Methotrexate—lung cancer	0.0285	0.0423	CbGbCtD
Olmesartan—Irbesartan—JUN—lung cancer	0.002	0.401	CrCbGaD
Olmesartan—Telmisartan—ABCG2—lung cancer	0.000837	0.167	CrCbGaD
Olmesartan—Losartan—UGT1A1—lung cancer	0.000774	0.155	CrCbGaD
Olmesartan—Valsartan—ALB—lung cancer	0.000388	0.0776	CrCbGaD
Olmesartan—Telmisartan—ABCB1—lung cancer	0.000348	0.0696	CrCbGaD
Olmesartan—Candesartan—ABCB1—lung cancer	0.000281	0.0561	CrCbGaD
Olmesartan—Losartan—ALB—lung cancer	0.00019	0.0379	CrCbGaD
Olmesartan—Losartan—ABCB1—lung cancer	0.000181	0.0362	CrCbGaD
Olmesartan—Pain—Cisplatin—lung cancer	0.000117	0.000508	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000117	0.000506	CcSEcCtD
Olmesartan—Vomiting—Vinorelbine—lung cancer	0.000117	0.000504	CcSEcCtD
Olmesartan—Body temperature increased—Gemcitabine—lung cancer	0.000116	0.000504	CcSEcCtD
Olmesartan—Renal failure—Methotrexate—lung cancer	0.000116	0.000502	CcSEcCtD
Olmesartan—Rash—Vinorelbine—lung cancer	0.000116	0.0005	CcSEcCtD
Olmesartan—Dermatitis—Vinorelbine—lung cancer	0.000116	0.0005	CcSEcCtD
Olmesartan—Hypotension—Paclitaxel—lung cancer	0.000115	0.000498	CcSEcCtD
Olmesartan—Headache—Vinorelbine—lung cancer	0.000115	0.000497	CcSEcCtD
Olmesartan—Syncope—Docetaxel—lung cancer	0.000115	0.000497	CcSEcCtD
Olmesartan—Influenza—Doxorubicin—lung cancer	0.000115	0.000496	CcSEcCtD
Olmesartan—Leukopenia—Docetaxel—lung cancer	0.000115	0.000496	CcSEcCtD
Olmesartan—Eosinophilia—Doxorubicin—lung cancer	0.000114	0.000491	CcSEcCtD
Olmesartan—Palpitations—Docetaxel—lung cancer	0.000113	0.00049	CcSEcCtD
Olmesartan—Feeling abnormal—Cisplatin—lung cancer	0.000113	0.000489	CcSEcCtD
Olmesartan—Haematuria—Methotrexate—lung cancer	0.000113	0.000487	CcSEcCtD
Olmesartan—Loss of consciousness—Docetaxel—lung cancer	0.000113	0.000487	CcSEcCtD
Olmesartan—Pancreatitis—Doxorubicin—lung cancer	0.000113	0.000486	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000112	0.000486	CcSEcCtD
Olmesartan—Cough—Docetaxel—lung cancer	0.000112	0.000483	CcSEcCtD
Olmesartan—Angina pectoris—Doxorubicin—lung cancer	0.000112	0.000483	CcSEcCtD
Olmesartan—Insomnia—Paclitaxel—lung cancer	0.000112	0.000482	CcSEcCtD
Olmesartan—Bronchitis—Doxorubicin—lung cancer	0.00011	0.000477	CcSEcCtD
Olmesartan—Agranulocytosis—Methotrexate—lung cancer	0.00011	0.000477	CcSEcCtD
Olmesartan—Decreased appetite—Etoposide—lung cancer	0.000109	0.000473	CcSEcCtD
Olmesartan—Myalgia—Docetaxel—lung cancer	0.000109	0.000472	CcSEcCtD
Olmesartan—Arthralgia—Docetaxel—lung cancer	0.000109	0.000472	CcSEcCtD
Olmesartan—Chest pain—Docetaxel—lung cancer	0.000109	0.000472	CcSEcCtD
Olmesartan—Pancytopenia—Doxorubicin—lung cancer	0.000109	0.000471	CcSEcCtD
Olmesartan—Nausea—Vinorelbine—lung cancer	0.000109	0.000471	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Etoposide—lung cancer	0.000109	0.00047	CcSEcCtD
Olmesartan—Dyspepsia—Paclitaxel—lung cancer	0.000109	0.00047	CcSEcCtD
Olmesartan—Body temperature increased—Cisplatin—lung cancer	0.000109	0.000469	CcSEcCtD
Olmesartan—Asthenia—Irinotecan—lung cancer	0.000109	0.000469	CcSEcCtD
Olmesartan—Fatigue—Etoposide—lung cancer	0.000108	0.000469	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000108	0.000468	CcSEcCtD
Olmesartan—Pain—Etoposide—lung cancer	0.000108	0.000465	CcSEcCtD
Olmesartan—Constipation—Etoposide—lung cancer	0.000108	0.000465	CcSEcCtD
Olmesartan—Neutropenia—Doxorubicin—lung cancer	0.000107	0.000464	CcSEcCtD
Olmesartan—Decreased appetite—Paclitaxel—lung cancer	0.000107	0.000464	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000107	0.000461	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000107	0.00046	CcSEcCtD
Olmesartan—Fatigue—Paclitaxel—lung cancer	0.000106	0.00046	CcSEcCtD
Olmesartan—Asthenia—Gemcitabine—lung cancer	0.000106	0.000457	CcSEcCtD
Olmesartan—Pain—Paclitaxel—lung cancer	0.000106	0.000456	CcSEcCtD
Olmesartan—Constipation—Paclitaxel—lung cancer	0.000106	0.000456	CcSEcCtD
Olmesartan—Pharyngitis—Methotrexate—lung cancer	0.000105	0.000455	CcSEcCtD
Olmesartan—Urinary tract disorder—Methotrexate—lung cancer	0.000105	0.000453	CcSEcCtD
Olmesartan—Photosensitivity reaction—Doxorubicin—lung cancer	0.000105	0.000453	CcSEcCtD
Olmesartan—Anaphylactic shock—Docetaxel—lung cancer	0.000105	0.000452	CcSEcCtD
Olmesartan—Oedema—Docetaxel—lung cancer	0.000105	0.000452	CcSEcCtD
Olmesartan—Pruritus—Gemcitabine—lung cancer	0.000104	0.000451	CcSEcCtD
Olmesartan—Urethral disorder—Methotrexate—lung cancer	0.000104	0.00045	CcSEcCtD
Olmesartan—Infection—Docetaxel—lung cancer	0.000104	0.000449	CcSEcCtD
Olmesartan—Feeling abnormal—Etoposide—lung cancer	0.000104	0.000448	CcSEcCtD
Olmesartan—Hyperglycaemia—Doxorubicin—lung cancer	0.000104	0.000448	CcSEcCtD
Olmesartan—Diarrhoea—Irinotecan—lung cancer	0.000104	0.000447	CcSEcCtD
Olmesartan—Pneumonia—Doxorubicin—lung cancer	0.000103	0.000445	CcSEcCtD
Olmesartan—Gastrointestinal pain—Etoposide—lung cancer	0.000103	0.000445	CcSEcCtD
Olmesartan—Shock—Docetaxel—lung cancer	0.000103	0.000445	CcSEcCtD
Olmesartan—Nervous system disorder—Docetaxel—lung cancer	0.000103	0.000443	CcSEcCtD
Olmesartan—Thrombocytopenia—Docetaxel—lung cancer	0.000102	0.000443	CcSEcCtD
Olmesartan—Infestation NOS—Doxorubicin—lung cancer	0.000102	0.000442	CcSEcCtD
Olmesartan—Infestation—Doxorubicin—lung cancer	0.000102	0.000442	CcSEcCtD
Olmesartan—Tachycardia—Docetaxel—lung cancer	0.000102	0.000441	CcSEcCtD
Olmesartan—Feeling abnormal—Paclitaxel—lung cancer	0.000102	0.00044	CcSEcCtD
Olmesartan—Skin disorder—Docetaxel—lung cancer	0.000102	0.000439	CcSEcCtD
Olmesartan—Gastrointestinal pain—Paclitaxel—lung cancer	0.000101	0.000436	CcSEcCtD
Olmesartan—Diarrhoea—Gemcitabine—lung cancer	0.000101	0.000436	CcSEcCtD
Olmesartan—Renal failure—Doxorubicin—lung cancer	0.000101	0.000435	CcSEcCtD
Olmesartan—Dizziness—Irinotecan—lung cancer	0.0001	0.000432	CcSEcCtD
Olmesartan—Urticaria—Etoposide—lung cancer	0.0001	0.000432	CcSEcCtD
Olmesartan—Jaundice—Doxorubicin—lung cancer	9.98e-05	0.000431	CcSEcCtD
Olmesartan—Anorexia—Docetaxel—lung cancer	9.97e-05	0.000431	CcSEcCtD
Olmesartan—Abdominal pain—Etoposide—lung cancer	9.95e-05	0.00043	CcSEcCtD
Olmesartan—Body temperature increased—Etoposide—lung cancer	9.95e-05	0.00043	CcSEcCtD
Olmesartan—Urinary tract infection—Doxorubicin—lung cancer	9.95e-05	0.00043	CcSEcCtD
Olmesartan—Asthenia—Cisplatin—lung cancer	9.86e-05	0.000426	CcSEcCtD
Olmesartan—Urticaria—Paclitaxel—lung cancer	9.8e-05	0.000424	CcSEcCtD
Olmesartan—Hypotension—Docetaxel—lung cancer	9.77e-05	0.000422	CcSEcCtD
Olmesartan—Haematuria—Doxorubicin—lung cancer	9.76e-05	0.000422	CcSEcCtD
Olmesartan—Abdominal pain—Paclitaxel—lung cancer	9.75e-05	0.000422	CcSEcCtD
Olmesartan—Body temperature increased—Paclitaxel—lung cancer	9.75e-05	0.000422	CcSEcCtD
Olmesartan—Angiopathy—Methotrexate—lung cancer	9.63e-05	0.000416	CcSEcCtD
Olmesartan—Vomiting—Irinotecan—lung cancer	9.62e-05	0.000416	CcSEcCtD
Olmesartan—Sinusitis—Doxorubicin—lung cancer	9.6e-05	0.000415	CcSEcCtD
Olmesartan—Mediastinal disorder—Methotrexate—lung cancer	9.56e-05	0.000413	CcSEcCtD
Olmesartan—Agranulocytosis—Doxorubicin—lung cancer	9.55e-05	0.000413	CcSEcCtD
Olmesartan—Rash—Irinotecan—lung cancer	9.54e-05	0.000412	CcSEcCtD
Olmesartan—Dermatitis—Irinotecan—lung cancer	9.53e-05	0.000412	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Docetaxel—lung cancer	9.53e-05	0.000412	CcSEcCtD
Olmesartan—Headache—Irinotecan—lung cancer	9.48e-05	0.00041	CcSEcCtD
Olmesartan—Insomnia—Docetaxel—lung cancer	9.46e-05	0.000409	CcSEcCtD
Olmesartan—Diarrhoea—Cisplatin—lung cancer	9.4e-05	0.000406	CcSEcCtD
Olmesartan—Alopecia—Methotrexate—lung cancer	9.38e-05	0.000405	CcSEcCtD
Olmesartan—Vomiting—Gemcitabine—lung cancer	9.37e-05	0.000405	CcSEcCtD
Olmesartan—Mental disorder—Methotrexate—lung cancer	9.3e-05	0.000402	CcSEcCtD
Olmesartan—Rash—Gemcitabine—lung cancer	9.29e-05	0.000402	CcSEcCtD
Olmesartan—Dermatitis—Gemcitabine—lung cancer	9.28e-05	0.000401	CcSEcCtD
Olmesartan—Malnutrition—Methotrexate—lung cancer	9.24e-05	0.000399	CcSEcCtD
Olmesartan—Headache—Gemcitabine—lung cancer	9.23e-05	0.000399	CcSEcCtD
Olmesartan—Rhinitis—Doxorubicin—lung cancer	9.21e-05	0.000398	CcSEcCtD
Olmesartan—Dyspepsia—Docetaxel—lung cancer	9.21e-05	0.000398	CcSEcCtD
Olmesartan—Pharyngitis—Doxorubicin—lung cancer	9.12e-05	0.000394	CcSEcCtD
Olmesartan—Decreased appetite—Docetaxel—lung cancer	9.09e-05	0.000393	CcSEcCtD
Olmesartan—Urinary tract disorder—Doxorubicin—lung cancer	9.07e-05	0.000392	CcSEcCtD
Olmesartan—Oedema peripheral—Doxorubicin—lung cancer	9.05e-05	0.000391	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Docetaxel—lung cancer	9.03e-05	0.00039	CcSEcCtD
Olmesartan—Asthenia—Etoposide—lung cancer	9.03e-05	0.00039	CcSEcCtD
Olmesartan—Connective tissue disorder—Doxorubicin—lung cancer	9.03e-05	0.00039	CcSEcCtD
Olmesartan—Fatigue—Docetaxel—lung cancer	9.02e-05	0.00039	CcSEcCtD
Olmesartan—Urethral disorder—Doxorubicin—lung cancer	9.01e-05	0.000389	CcSEcCtD
Olmesartan—Nausea—Irinotecan—lung cancer	8.99e-05	0.000388	CcSEcCtD
Olmesartan—Pain—Docetaxel—lung cancer	8.94e-05	0.000387	CcSEcCtD
Olmesartan—Constipation—Docetaxel—lung cancer	8.94e-05	0.000387	CcSEcCtD
Olmesartan—Back pain—Methotrexate—lung cancer	8.93e-05	0.000386	CcSEcCtD
Olmesartan—Pruritus—Etoposide—lung cancer	8.9e-05	0.000385	CcSEcCtD
Olmesartan—Asthenia—Paclitaxel—lung cancer	8.85e-05	0.000383	CcSEcCtD
Olmesartan—Nausea—Gemcitabine—lung cancer	8.75e-05	0.000378	CcSEcCtD
Olmesartan—Vomiting—Cisplatin—lung cancer	8.73e-05	0.000378	CcSEcCtD
Olmesartan—Pruritus—Paclitaxel—lung cancer	8.73e-05	0.000377	CcSEcCtD
Olmesartan—Vision blurred—Methotrexate—lung cancer	8.7e-05	0.000376	CcSEcCtD
Olmesartan—Rash—Cisplatin—lung cancer	8.66e-05	0.000374	CcSEcCtD
Olmesartan—Dermatitis—Cisplatin—lung cancer	8.65e-05	0.000374	CcSEcCtD
Olmesartan—Feeling abnormal—Docetaxel—lung cancer	8.62e-05	0.000373	CcSEcCtD
Olmesartan—Diarrhoea—Etoposide—lung cancer	8.61e-05	0.000372	CcSEcCtD
Olmesartan—Ill-defined disorder—Methotrexate—lung cancer	8.57e-05	0.00037	CcSEcCtD
Olmesartan—Gastrointestinal pain—Docetaxel—lung cancer	8.55e-05	0.00037	CcSEcCtD
Olmesartan—Anaemia—Methotrexate—lung cancer	8.54e-05	0.000369	CcSEcCtD
Olmesartan—Diarrhoea—Paclitaxel—lung cancer	8.44e-05	0.000365	CcSEcCtD
Olmesartan—Angiopathy—Doxorubicin—lung cancer	8.34e-05	0.00036	CcSEcCtD
Olmesartan—Malaise—Methotrexate—lung cancer	8.33e-05	0.00036	CcSEcCtD
Olmesartan—Dizziness—Etoposide—lung cancer	8.32e-05	0.00036	CcSEcCtD
Olmesartan—Vertigo—Methotrexate—lung cancer	8.3e-05	0.000359	CcSEcCtD
Olmesartan—Mediastinal disorder—Doxorubicin—lung cancer	8.28e-05	0.000358	CcSEcCtD
Olmesartan—Body temperature increased—Docetaxel—lung cancer	8.27e-05	0.000357	CcSEcCtD
Olmesartan—Abdominal pain—Docetaxel—lung cancer	8.27e-05	0.000357	CcSEcCtD
Olmesartan—Leukopenia—Methotrexate—lung cancer	8.27e-05	0.000357	CcSEcCtD
Olmesartan—Arrhythmia—Doxorubicin—lung cancer	8.21e-05	0.000355	CcSEcCtD
Olmesartan—Dizziness—Paclitaxel—lung cancer	8.16e-05	0.000353	CcSEcCtD
Olmesartan—Nausea—Cisplatin—lung cancer	8.16e-05	0.000353	CcSEcCtD
Olmesartan—Alopecia—Doxorubicin—lung cancer	8.12e-05	0.000351	CcSEcCtD
Olmesartan—Cough—Methotrexate—lung cancer	8.06e-05	0.000348	CcSEcCtD
Olmesartan—Mental disorder—Doxorubicin—lung cancer	8.05e-05	0.000348	CcSEcCtD
Olmesartan—Vomiting—Etoposide—lung cancer	8e-05	0.000346	CcSEcCtD
Olmesartan—Malnutrition—Doxorubicin—lung cancer	8e-05	0.000346	CcSEcCtD
Olmesartan—Rash—Etoposide—lung cancer	7.93e-05	0.000343	CcSEcCtD
Olmesartan—Dermatitis—Etoposide—lung cancer	7.93e-05	0.000343	CcSEcCtD
Olmesartan—Headache—Etoposide—lung cancer	7.88e-05	0.000341	CcSEcCtD
Olmesartan—Arthralgia—Methotrexate—lung cancer	7.86e-05	0.00034	CcSEcCtD
Olmesartan—Myalgia—Methotrexate—lung cancer	7.86e-05	0.00034	CcSEcCtD
Olmesartan—Chest pain—Methotrexate—lung cancer	7.86e-05	0.00034	CcSEcCtD
Olmesartan—Vomiting—Paclitaxel—lung cancer	7.85e-05	0.000339	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.81e-05	0.000338	CcSEcCtD
Olmesartan—Rash—Paclitaxel—lung cancer	7.78e-05	0.000336	CcSEcCtD
Olmesartan—Dermatitis—Paclitaxel—lung cancer	7.77e-05	0.000336	CcSEcCtD
Olmesartan—Discomfort—Methotrexate—lung cancer	7.77e-05	0.000336	CcSEcCtD
Olmesartan—Back pain—Doxorubicin—lung cancer	7.74e-05	0.000334	CcSEcCtD
Olmesartan—Headache—Paclitaxel—lung cancer	7.73e-05	0.000334	CcSEcCtD
Olmesartan—Muscle spasms—Doxorubicin—lung cancer	7.69e-05	0.000332	CcSEcCtD
Olmesartan—Anaphylactic shock—Methotrexate—lung cancer	7.54e-05	0.000326	CcSEcCtD
Olmesartan—Vision blurred—Doxorubicin—lung cancer	7.54e-05	0.000326	CcSEcCtD
Olmesartan—Asthenia—Docetaxel—lung cancer	7.5e-05	0.000324	CcSEcCtD
Olmesartan—Infection—Methotrexate—lung cancer	7.49e-05	0.000324	CcSEcCtD
Olmesartan—Nausea—Etoposide—lung cancer	7.47e-05	0.000323	CcSEcCtD
Olmesartan—Ill-defined disorder—Doxorubicin—lung cancer	7.42e-05	0.000321	CcSEcCtD
Olmesartan—Pruritus—Docetaxel—lung cancer	7.4e-05	0.00032	CcSEcCtD
Olmesartan—Nervous system disorder—Methotrexate—lung cancer	7.39e-05	0.00032	CcSEcCtD
Olmesartan—Anaemia—Doxorubicin—lung cancer	7.39e-05	0.00032	CcSEcCtD
Olmesartan—Thrombocytopenia—Methotrexate—lung cancer	7.38e-05	0.000319	CcSEcCtD
Olmesartan—Agitation—Doxorubicin—lung cancer	7.35e-05	0.000318	CcSEcCtD
Olmesartan—Nausea—Paclitaxel—lung cancer	7.33e-05	0.000317	CcSEcCtD
Olmesartan—Skin disorder—Methotrexate—lung cancer	7.32e-05	0.000316	CcSEcCtD
Olmesartan—Hyperhidrosis—Methotrexate—lung cancer	7.29e-05	0.000315	CcSEcCtD
Olmesartan—Malaise—Doxorubicin—lung cancer	7.21e-05	0.000312	CcSEcCtD
Olmesartan—Vertigo—Doxorubicin—lung cancer	7.19e-05	0.000311	CcSEcCtD
Olmesartan—Anorexia—Methotrexate—lung cancer	7.19e-05	0.000311	CcSEcCtD
Olmesartan—Syncope—Doxorubicin—lung cancer	7.17e-05	0.00031	CcSEcCtD
Olmesartan—Leukopenia—Doxorubicin—lung cancer	7.16e-05	0.000309	CcSEcCtD
Olmesartan—Diarrhoea—Docetaxel—lung cancer	7.16e-05	0.000309	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—APP—lung cancer	7.08e-05	0.00079	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	7.08e-05	0.000789	CbGpPWpGaD
Olmesartan—Palpitations—Doxorubicin—lung cancer	7.07e-05	0.000306	CcSEcCtD
Olmesartan—Hypotension—Methotrexate—lung cancer	7.04e-05	0.000304	CcSEcCtD
Olmesartan—Loss of consciousness—Doxorubicin—lung cancer	7.03e-05	0.000304	CcSEcCtD
Olmesartan—Cough—Doxorubicin—lung cancer	6.98e-05	0.000302	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—RHEB—lung cancer	6.98e-05	0.000778	CbGpPWpGaD
Olmesartan—Dizziness—Docetaxel—lung cancer	6.92e-05	0.000299	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—RRM1—lung cancer	6.9e-05	0.00077	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTA3—lung cancer	6.9e-05	0.00077	CbGpPWpGaD
Olmesartan—Musculoskeletal discomfort—Methotrexate—lung cancer	6.87e-05	0.000297	CcSEcCtD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ABCG2—lung cancer	6.86e-05	0.000765	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ADCY1—lung cancer	6.86e-05	0.000765	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	6.83e-05	0.000761	CbGpPWpGaD
Olmesartan—Insomnia—Methotrexate—lung cancer	6.82e-05	0.000295	CcSEcCtD
Olmesartan—Arthralgia—Doxorubicin—lung cancer	6.81e-05	0.000294	CcSEcCtD
Olmesartan—Myalgia—Doxorubicin—lung cancer	6.81e-05	0.000294	CcSEcCtD
Olmesartan—Chest pain—Doxorubicin—lung cancer	6.81e-05	0.000294	CcSEcCtD
Olmesartan—ABCC2—Transmembrane transport of small molecules—TF—lung cancer	6.79e-05	0.000757	CbGpPWpGaD
Olmesartan—Anxiety—Doxorubicin—lung cancer	6.79e-05	0.000293	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—ANXA1—lung cancer	6.78e-05	0.000756	CbGpPWpGaD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.76e-05	0.000292	CcSEcCtD
Olmesartan—Discomfort—Doxorubicin—lung cancer	6.73e-05	0.000291	CcSEcCtD
Olmesartan—Vomiting—Docetaxel—lung cancer	6.65e-05	0.000287	CcSEcCtD
Olmesartan—Dyspepsia—Methotrexate—lung cancer	6.64e-05	0.000287	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—GRM8—lung cancer	6.61e-05	0.000737	CbGpPWpGaD
Olmesartan—Rash—Docetaxel—lung cancer	6.59e-05	0.000285	CcSEcCtD
Olmesartan—Dermatitis—Docetaxel—lung cancer	6.59e-05	0.000285	CcSEcCtD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—AVP—lung cancer	6.58e-05	0.000734	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HSD17B10—lung cancer	6.58e-05	0.000734	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	6.58e-05	0.000733	CbGpPWpGaD
Olmesartan—Decreased appetite—Methotrexate—lung cancer	6.55e-05	0.000283	CcSEcCtD
Olmesartan—Headache—Docetaxel—lung cancer	6.55e-05	0.000283	CcSEcCtD
Olmesartan—Oedema—Doxorubicin—lung cancer	6.53e-05	0.000282	CcSEcCtD
Olmesartan—Anaphylactic shock—Doxorubicin—lung cancer	6.53e-05	0.000282	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Methotrexate—lung cancer	6.51e-05	0.000281	CcSEcCtD
Olmesartan—Fatigue—Methotrexate—lung cancer	6.5e-05	0.000281	CcSEcCtD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	6.49e-05	0.000724	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—B4GALT5—lung cancer	6.49e-05	0.000724	CbGpPWpGaD
Olmesartan—Infection—Doxorubicin—lung cancer	6.48e-05	0.00028	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—POMC—lung cancer	6.48e-05	0.000722	CbGpPWpGaD
Olmesartan—Pain—Methotrexate—lung cancer	6.45e-05	0.000279	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—APP—lung cancer	6.43e-05	0.000717	CbGpPWpGaD
Olmesartan—Shock—Doxorubicin—lung cancer	6.42e-05	0.000278	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—SKI—lung cancer	6.41e-05	0.000714	CbGpPWpGaD
Olmesartan—Nervous system disorder—Doxorubicin—lung cancer	6.4e-05	0.000277	CcSEcCtD
Olmesartan—Thrombocytopenia—Doxorubicin—lung cancer	6.39e-05	0.000276	CcSEcCtD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—TF—lung cancer	6.38e-05	0.000711	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ABCB1—lung cancer	6.38e-05	0.000711	CbGpPWpGaD
Olmesartan—Tachycardia—Doxorubicin—lung cancer	6.37e-05	0.000275	CcSEcCtD
Olmesartan—Skin disorder—Doxorubicin—lung cancer	6.34e-05	0.000274	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—GSTA4—lung cancer	6.31e-05	0.000704	CbGpPWpGaD
Olmesartan—Hyperhidrosis—Doxorubicin—lung cancer	6.31e-05	0.000273	CcSEcCtD
Olmesartan—AGTR1—G alpha (q) signalling events—PIK3CA—lung cancer	6.3e-05	0.000703	CbGpPWpGaD
Olmesartan—Anorexia—Doxorubicin—lung cancer	6.22e-05	0.000269	CcSEcCtD
Olmesartan—Nausea—Docetaxel—lung cancer	6.21e-05	0.000269	CcSEcCtD
Olmesartan—Feeling abnormal—Methotrexate—lung cancer	6.21e-05	0.000269	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	6.17e-05	0.000688	CbGpPWpGaD
Olmesartan—Gastrointestinal pain—Methotrexate—lung cancer	6.16e-05	0.000266	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—GSTA2—lung cancer	6.15e-05	0.000686	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	6.14e-05	0.000684	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CKB—lung cancer	6.12e-05	0.000682	CbGpPWpGaD
Olmesartan—Hypotension—Doxorubicin—lung cancer	6.1e-05	0.000264	CcSEcCtD
Olmesartan—Urticaria—Methotrexate—lung cancer	5.99e-05	0.000259	CcSEcCtD
Olmesartan—Body temperature increased—Methotrexate—lung cancer	5.96e-05	0.000258	CcSEcCtD
Olmesartan—Abdominal pain—Methotrexate—lung cancer	5.96e-05	0.000258	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.95e-05	0.000257	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—GSTA1—lung cancer	5.94e-05	0.000662	CbGpPWpGaD
Olmesartan—Insomnia—Doxorubicin—lung cancer	5.9e-05	0.000255	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—ABCC3—lung cancer	5.87e-05	0.000654	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CNDP2—lung cancer	5.75e-05	0.000641	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTM2—lung cancer	5.75e-05	0.000641	CbGpPWpGaD
Olmesartan—Dyspepsia—Doxorubicin—lung cancer	5.75e-05	0.000248	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—AKR1C1—lung cancer	5.68e-05	0.000634	CbGpPWpGaD
Olmesartan—Decreased appetite—Doxorubicin—lung cancer	5.67e-05	0.000245	CcSEcCtD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	5.64e-05	0.000628	CbGpPWpGaD
Olmesartan—Gastrointestinal disorder—Doxorubicin—lung cancer	5.63e-05	0.000244	CcSEcCtD
Olmesartan—Fatigue—Doxorubicin—lung cancer	5.63e-05	0.000243	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—MTMR3—lung cancer	5.6e-05	0.000624	CbGpPWpGaD
Olmesartan—Pain—Doxorubicin—lung cancer	5.58e-05	0.000241	CcSEcCtD
Olmesartan—Constipation—Doxorubicin—lung cancer	5.58e-05	0.000241	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—PXN—lung cancer	5.56e-05	0.00062	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—UGT1A1—lung cancer	5.52e-05	0.000615	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AVP—lung cancer	5.51e-05	0.000614	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PGAM1—lung cancer	5.45e-05	0.000608	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKR1C1—lung cancer	5.45e-05	0.000607	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—OXTR—lung cancer	5.45e-05	0.000607	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GRP—lung cancer	5.45e-05	0.000607	CbGpPWpGaD
Olmesartan—Asthenia—Methotrexate—lung cancer	5.41e-05	0.000234	CcSEcCtD
Olmesartan—Feeling abnormal—Doxorubicin—lung cancer	5.38e-05	0.000233	CcSEcCtD
Olmesartan—Gastrointestinal pain—Doxorubicin—lung cancer	5.34e-05	0.000231	CcSEcCtD
Olmesartan—Pruritus—Methotrexate—lung cancer	5.33e-05	0.000231	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—GNG11—lung cancer	5.32e-05	0.000593	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOA1—lung cancer	5.29e-05	0.00059	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—lung cancer	5.27e-05	0.000588	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	5.21e-05	0.000581	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2A7—lung cancer	5.2e-05	0.00058	CbGpPWpGaD
Olmesartan—Urticaria—Doxorubicin—lung cancer	5.19e-05	0.000224	CcSEcCtD
Olmesartan—Body temperature increased—Doxorubicin—lung cancer	5.16e-05	0.000223	CcSEcCtD
Olmesartan—Abdominal pain—Doxorubicin—lung cancer	5.16e-05	0.000223	CcSEcCtD
Olmesartan—Diarrhoea—Methotrexate—lung cancer	5.16e-05	0.000223	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—GNG11—lung cancer	5.1e-05	0.000568	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SDC4—lung cancer	5.09e-05	0.000568	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALDOA—lung cancer	5.07e-05	0.000565	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—APOA1—lung cancer	5.03e-05	0.000561	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CXCL8—lung cancer	5.01e-05	0.000559	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AVP—lung cancer	5e-05	0.000558	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	4.99e-05	0.000556	CbGpPWpGaD
Olmesartan—Dizziness—Methotrexate—lung cancer	4.98e-05	0.000215	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—NCOA3—lung cancer	4.92e-05	0.000548	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFC—lung cancer	4.86e-05	0.000541	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.83e-05	0.000539	CbGpPWpGaD
Olmesartan—Vomiting—Methotrexate—lung cancer	4.79e-05	0.000207	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—ADCY1—lung cancer	4.78e-05	0.000533	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCG2—lung cancer	4.78e-05	0.000533	CbGpPWpGaD
Olmesartan—Rash—Methotrexate—lung cancer	4.75e-05	0.000205	CcSEcCtD
Olmesartan—Dermatitis—Methotrexate—lung cancer	4.75e-05	0.000205	CcSEcCtD
Olmesartan—Headache—Methotrexate—lung cancer	4.72e-05	0.000204	CcSEcCtD
Olmesartan—ABCC2—Transmembrane transport of small molecules—AVP—lung cancer	4.71e-05	0.000525	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HPGDS—lung cancer	4.69e-05	0.000523	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ENO2—lung cancer	4.69e-05	0.000523	CbGpPWpGaD
Olmesartan—Asthenia—Doxorubicin—lung cancer	4.68e-05	0.000202	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—PPP2R1B—lung cancer	4.66e-05	0.00052	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—RRM1—lung cancer	4.64e-05	0.000517	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTA3—lung cancer	4.64e-05	0.000517	CbGpPWpGaD
Olmesartan—Pruritus—Doxorubicin—lung cancer	4.62e-05	0.0002	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.6e-05	0.000513	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADCY1—lung cancer	4.59e-05	0.000511	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ABCB1—lung cancer	4.56e-05	0.000508	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTT1—lung cancer	4.55e-05	0.000507	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GCLC—lung cancer	4.5e-05	0.000502	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2A6—lung cancer	4.5e-05	0.000502	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.48e-05	0.0005	CbGpPWpGaD
Olmesartan—Nausea—Methotrexate—lung cancer	4.48e-05	0.000194	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—PPP2R1B—lung cancer	4.47e-05	0.000498	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SMARCA4—lung cancer	4.47e-05	0.000498	CbGpPWpGaD
Olmesartan—Diarrhoea—Doxorubicin—lung cancer	4.47e-05	0.000193	CcSEcCtD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—AVP—lung cancer	4.42e-05	0.000493	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—B4GALT5—lung cancer	4.36e-05	0.000486	CbGpPWpGaD
Olmesartan—Dizziness—Doxorubicin—lung cancer	4.32e-05	0.000187	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—HSPB1—lung cancer	4.31e-05	0.000481	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ABCB1—lung cancer	4.28e-05	0.000478	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ENO1—lung cancer	4.26e-05	0.000475	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTHLH—lung cancer	4.26e-05	0.000475	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—CREBBP—lung cancer	4.26e-05	0.000475	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.25e-05	0.000474	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTA4—lung cancer	4.24e-05	0.000473	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.19e-05	0.000468	CbGpPWpGaD
Olmesartan—Vomiting—Doxorubicin—lung cancer	4.15e-05	0.000179	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	4.15e-05	0.000462	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTA2—lung cancer	4.13e-05	0.000461	CbGpPWpGaD
Olmesartan—Rash—Doxorubicin—lung cancer	4.12e-05	0.000178	CcSEcCtD
Olmesartan—Dermatitis—Doxorubicin—lung cancer	4.11e-05	0.000178	CcSEcCtD
Olmesartan—Headache—Doxorubicin—lung cancer	4.09e-05	0.000177	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—ANXA1—lung cancer	4.01e-05	0.000447	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ALB—lung cancer	3.99e-05	0.000445	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTA1—lung cancer	3.99e-05	0.000445	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCC3—lung cancer	3.94e-05	0.00044	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FLT1—lung cancer	3.88e-05	0.000433	CbGpPWpGaD
Olmesartan—Nausea—Doxorubicin—lung cancer	3.88e-05	0.000168	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CG—lung cancer	3.85e-05	0.000429	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2E1—lung cancer	3.83e-05	0.000426	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AKR1C1—lung cancer	3.82e-05	0.000426	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOTCH3—lung cancer	3.8e-05	0.000424	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APP—lung cancer	3.8e-05	0.000424	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NQO1—lung cancer	3.78e-05	0.000422	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGF9—lung cancer	3.77e-05	0.00042	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—UGT1A1—lung cancer	3.71e-05	0.000413	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.7e-05	0.000413	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.67e-05	0.000409	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—POMC—lung cancer	3.66e-05	0.000408	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—RAF1—lung cancer	3.61e-05	0.000402	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—APOA1—lung cancer	3.6e-05	0.000401	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—JUNB—lung cancer	3.6e-05	0.000401	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GNG11—lung cancer	3.58e-05	0.000399	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.56e-05	0.000397	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CG—lung cancer	3.49e-05	0.000389	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—STK11—lung cancer	3.41e-05	0.00038	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALDOA—lung cancer	3.4e-05	0.000379	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—APOA1—lung cancer	3.38e-05	0.000377	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CD—lung cancer	3.38e-05	0.000377	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—POMC—lung cancer	3.32e-05	0.000371	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NCOA3—lung cancer	3.3e-05	0.000368	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STK11—lung cancer	3.27e-05	0.000364	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.25e-05	0.000362	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6R—lung cancer	3.24e-05	0.000361	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCG2—lung cancer	3.21e-05	0.000358	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ADCY1—lung cancer	3.21e-05	0.000358	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.2e-05	0.000357	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTP1—lung cancer	3.15e-05	0.000352	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FOXO3—lung cancer	3.15e-05	0.000352	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HPGDS—lung cancer	3.15e-05	0.000351	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ENO2—lung cancer	3.15e-05	0.000351	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPP2R1B—lung cancer	3.13e-05	0.000349	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.09e-05	0.000345	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MAP2K1—lung cancer	3.09e-05	0.000344	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CD—lung cancer	3.07e-05	0.000342	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAT—lung cancer	3.07e-05	0.000342	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTT1—lung cancer	3.06e-05	0.000341	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.05e-05	0.00034	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—CREBBP—lung cancer	3.05e-05	0.00034	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2A6—lung cancer	3.02e-05	0.000337	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GCLC—lung cancer	3.02e-05	0.000337	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.01e-05	0.000336	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCB1—lung cancer	2.99e-05	0.000333	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AVP—lung cancer	2.95e-05	0.000329	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CB—lung cancer	2.95e-05	0.000328	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—TYMS—lung cancer	2.93e-05	0.000327	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTM1—lung cancer	2.9e-05	0.000323	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ENO1—lung cancer	2.87e-05	0.000319	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—CREBBP—lung cancer	2.86e-05	0.000319	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.85e-05	0.000318	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ALB—lung cancer	2.85e-05	0.000318	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1R—lung cancer	2.84e-05	0.000317	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL8—lung cancer	2.83e-05	0.000316	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.82e-05	0.000314	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HES1—lung cancer	2.79e-05	0.000311	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP1A1—lung cancer	2.75e-05	0.000306	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—RAF1—lung cancer	2.74e-05	0.000306	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ERCC2—lung cancer	2.73e-05	0.000304	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL2—lung cancer	2.71e-05	0.000302	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ALB—lung cancer	2.68e-05	0.000299	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CB—lung cancer	2.68e-05	0.000298	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—RAF1—lung cancer	2.58e-05	0.000288	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL8—lung cancer	2.57e-05	0.000287	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2E1—lung cancer	2.57e-05	0.000287	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ERBB3—lung cancer	2.55e-05	0.000285	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NQO1—lung cancer	2.54e-05	0.000283	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.49e-05	0.000277	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.47e-05	0.000275	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL2—lung cancer	2.46e-05	0.000274	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TERT—lung cancer	2.45e-05	0.000273	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—RAF1—lung cancer	2.42e-05	0.00027	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGFR1—lung cancer	2.38e-05	0.000265	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOA1—lung cancer	2.36e-05	0.000263	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HIF1A—lung cancer	2.34e-05	0.000261	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—STK11—lung cancer	2.29e-05	0.000255	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOA1—lung cancer	2.26e-05	0.000252	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.26e-05	0.000252	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KDR—lung cancer	2.24e-05	0.00025	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CG—lung cancer	2.15e-05	0.00024	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.15e-05	0.00024	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTP1—lung cancer	2.12e-05	0.000236	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KIT—lung cancer	2.06e-05	0.00023	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APC—lung cancer	2.06e-05	0.00023	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CG—lung cancer	2.06e-05	0.00023	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—NRAS—lung cancer	2.06e-05	0.00023	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAT—lung cancer	2.06e-05	0.00023	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.05e-05	0.000229	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—POMC—lung cancer	2.05e-05	0.000228	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EGF—lung cancer	2.04e-05	0.000227	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCB1—lung cancer	2.01e-05	0.000224	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CREBBP—lung cancer	2e-05	0.000222	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MAPK3—lung cancer	1.98e-05	0.00022	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TYMS—lung cancer	1.97e-05	0.00022	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—POMC—lung cancer	1.96e-05	0.000219	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTM1—lung cancer	1.95e-05	0.000217	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BRAF—lung cancer	1.94e-05	0.000216	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6R—lung cancer	1.92e-05	0.000214	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CREBBP—lung cancer	1.91e-05	0.000213	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CD—lung cancer	1.89e-05	0.000211	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EGFR—lung cancer	1.88e-05	0.00021	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALB—lung cancer	1.87e-05	0.000208	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP1A1—lung cancer	1.85e-05	0.000206	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ERCC2—lung cancer	1.83e-05	0.000204	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAP2K1—lung cancer	1.83e-05	0.000203	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CD—lung cancer	1.81e-05	0.000202	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CA—lung cancer	1.8e-05	0.0002	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—KRAS—lung cancer	1.78e-05	0.000198	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CB—lung cancer	1.65e-05	0.000184	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—lung cancer	1.63e-05	0.000182	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CA—lung cancer	1.63e-05	0.000182	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MDM2—lung cancer	1.62e-05	0.000181	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RAF1—lung cancer	1.62e-05	0.00018	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ERBB2—lung cancer	1.6e-05	0.000179	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOA1—lung cancer	1.58e-05	0.000177	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CB—lung cancer	1.58e-05	0.000176	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MTOR—lung cancer	1.58e-05	0.000176	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL8—lung cancer	1.52e-05	0.000169	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.52e-05	0.000169	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HRAS—lung cancer	1.51e-05	0.000168	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT1—lung cancer	1.47e-05	0.000164	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CASP3—lung cancer	1.45e-05	0.000162	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL2—lung cancer	1.45e-05	0.000162	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CG—lung cancer	1.45e-05	0.000161	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—lung cancer	1.44e-05	0.000161	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTEN—lung cancer	1.43e-05	0.000159	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCND1—lung cancer	1.42e-05	0.000158	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—JUN—lung cancer	1.41e-05	0.000157	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—POMC—lung cancer	1.38e-05	0.000153	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP9—lung cancer	1.37e-05	0.000153	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN1A—lung cancer	1.37e-05	0.000153	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTEN—lung cancer	1.37e-05	0.000152	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—EP300—lung cancer	1.36e-05	0.000152	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CREBBP—lung cancer	1.34e-05	0.000149	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT1—lung cancer	1.33e-05	0.000149	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EP300—lung cancer	1.3e-05	0.000145	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CD—lung cancer	1.27e-05	0.000142	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SRC—lung cancer	1.27e-05	0.000141	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALB—lung cancer	1.26e-05	0.00014	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—lung cancer	1.23e-05	0.000138	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STAT3—lung cancer	1.22e-05	0.000136	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NRAS—lung cancer	1.22e-05	0.000136	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK3—lung cancer	1.17e-05	0.00013	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MYC—lung cancer	1.14e-05	0.000127	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EGFR—lung cancer	1.11e-05	0.000124	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CB—lung cancer	1.11e-05	0.000124	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—lung cancer	1.1e-05	0.000122	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KRAS—lung cancer	1.05e-05	0.000117	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CA—lung cancer	1.01e-05	0.000112	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CA—lung cancer	9.64e-06	0.000107	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTEN—lung cancer	9.58e-06	0.000107	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TP53—lung cancer	9.32e-06	0.000104	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—EP300—lung cancer	9.13e-06	0.000102	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HRAS—lung cancer	8.91e-06	9.94e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—lung cancer	8.53e-06	9.51e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AKT1—lung cancer	8.21e-06	9.16e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT1—lung cancer	7.87e-06	8.77e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CA—lung cancer	6.76e-06	7.53e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AKT1—lung cancer	5.52e-06	6.15e-05	CbGpPWpGaD
